About the position
AstraZeneca is a global, science-led, patient-focused biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines for some of the world's most serious diseases. In the Oncology Business Unit, we relentlessly follow the science, challenging the status quo to deliver more effective treatments to patients in need. Our commitment means we purposefully push back the limits of knowledge to change the practice of medicine. To ensure no patient is left behind, no matter what stage of disease. Join a highly valued, strategic team that is fundamental in realizing the potential of our life-changing medicines. It's through our work that AstraZeneca is able to ensure the right access is provided to our transformative medicines. Working with new drugs, new treatment modalities, new digital approaches and ever-changing environments, it's crucial that we remain flexible and on top of the detail. Running, thinking and acting fast to make smart decisions and get the right medicines to patients at the right time. We lead the way for the industry with our pioneering valued-based agreements and Innovative Value Strategy solutions. It's our determination and unwavering belief in the power of our medicines, and the science sitting behind them, that drives us to ensure their value is realized. Inspired by our people, patients and pipeline, we work cross-functionally to leverage our shared skills, knowledge and entrepreneurial spirit to change the way medicines are assessed and perceived, and turn ambitions into reality. We're pioneering Market Access innovations: this is the place to unlock opportunities and feed our love for the challenge.
Responsibilities
- Lead on new technology assets including cell therapy -autologous, in-vivo and allogeneic and radioconjugates.
- Collaborate with early assets team including P&MA and Health Economics and Payer Evidence teams at the global, regional and local level.
- Represent OMAP on relevant Global project teams (GPTs) and Integrated Business Teams (IBTs).
- Develop Global Price and Market Access Strategy for Early Assets including business development.
- Provide robust pricing inputs and assumptions for investment decisions and internal forecasts.
- Provide input and guidance on early Clinical Development Plans.
- Provide input and guidance on regulatory trial designs, target product profiles and endpoints vs payer needs.
- Develop national to regional to local access insights for cell and radio conjugates across geographies.
- Develop policy narratives to support access and reimbursement for cell and radioconjugates.
- Develop early value messages and claims that meet payer needs across regions.
- Identify evidence gaps and solutions.
- Matrix manage a cross functional team to support the development of global price and market access strategy.
- Revise pricing & market access strategies and value stories to optimize life cycle management opportunities.
- Drive payer insights to ensure robust and validated price & reimbursement strategies.
- Plan launch and commercialisation activities, budget and timings to achieve global reimbursement and access.
Requirements
- Graduate degree in biomedical science, business, or economics or similar.
- Proven P&MA experience and a minimum of 7 years pharmaceutical or consulting experience.
- Oncology therapy area expertise is essential.
- Relevant drug development and/or commercialization experience within the pharmaceutical/medical industry.
- Knowledge of the needs and expectations of national and regional payers, insurers, and commercial customers.
- Ability to make reasoned decisions under pressure.
- Ability to take people with you and bring the best out of others.
- Excellence and precision in communication: credible and persuasive.
Nice-to-haves
- Previous experience with cell, gene therapy or radioconjugates.
- Experience working with clinicians, pharmacists and payers on evidence-based customer solutions.
- Experience in a commercial strategy function, e.g. managed markets brand director, business development director, head of pricing/access.
- Experience constructing payer value stories and incorporating these into TPPs.
- Experience in country or regional pharmaceutical role.
Benefits
- Inclusive and equitable environment.
- Commitment to lifelong learning, growth and development.
- Access to industry-leading research, technology, and a unique pipeline.
